Sep 27, 2018 GW Pharma cannabis drug set to hit market following DEA nod GW Pharma cannabis drug set to hit market following DEA nodUS-listed shares of GW Pharmaceuticals rose 8% on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug ... read morePublished on 2018-09-27